Chronic Kidney Disease

What is Chronic Kidney Disease?

Chronic Kidney Disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to filter waste products and excess fluids from the blood. This progressive deterioration occurs over months to years, often without noticeable symptoms in early stages. CKD affects approximately 10% of the global population, making it one of the most common chronic diseases worldwide. The condition is particularly prevalent among older adults, people with diabetes, and those with high blood pressure.

Key statistics

Symptoms

Early stages: Often asymptomatic or mild symptoms including fatigue, difficulty concentrating, poor appetite, trouble sleeping.

Progressive symptoms: Swelling in feet and ankles, muscle cramps, frequent urination (especially at night), persistent itching, chest pain, shortness of breath, high blood pressure.

Advanced symptoms: Severe fatigue and weakness, nausea and vomiting, changes in urination patterns, metallic taste in mouth, ammonia breath, severe fluid retention, confusion, seizures.

Submit Your Paper

Early-stage CKD is often called a “silent” disease because symptoms typically don’t appear until kidney function has declined significantly. Fatigue occurs because damaged kidneys produce less erythropoietin, a hormone that stimulates red blood cell production. Fluid retention happens as kidneys lose their ability to regulate fluid balance, leading to swelling in the extremities and potentially around the heart and lungs. The buildup of waste products in advanced stages can affect brain function and cause the characteristic uremic symptoms.

Causes and risk factors

Primary causes: Diabetes mellitus (responsible for approximately 40% of cases), hypertension (28% of cases), glomerulonephritis, polycystic kidney disease, autoimmune diseases, genetic disorders, prolonged obstruction of the urinary tract.

Major risk factors: Age over 60, family history of kidney disease, cardiovascular disease, obesity, smoking, excessive use of NSAIDs, certain infections, exposure to heavy metals or certain chemicals. Diabetes and hypertension often work together to accelerate kidney damage, with high blood sugar levels damaging the small blood vessels in the kidneys while elevated blood pressure puts additional strain on these already compromised filtering units. Genetic factors play a role in conditions like polycystic kidney disease and certain hereditary nephritis syndromes.

Prevention

Evidence-based prevention focuses on managing underlying conditions and lifestyle modifications. Maintain optimal blood sugar control if diabetic (HbA1c Complications

Without proper management, CKD leads to serious complications including cardiovascular disease (the leading cause of death in CKD patients), bone disease due to calcium and phosphorus imbalances, anemia from reduced erythropoietin production, mineral and electrolyte disorders, increased infection risk, and eventually kidney failure requiring dialysis or transplantation. Secondary hyperparathyroidism develops as kidneys lose their ability to activate vitamin D and regulate phosphorus. Uremia, the buildup of toxic waste products, can affect multiple organ systems including the brain, heart, and digestive system. CKD patients face a 10-20 times higher risk of cardiovascular events compared to the general population.

Diagnosis

CKD diagnosis relies on laboratory tests and clinical evaluation. Key diagnostic tests include serum creatinine levels used to calculate estimated glomerular filtration rate (eGFR), urinalysis to detect proteinuria or hematuria, and urine albumin-to-creatinine ratio (ACR). Imaging studies such as kidney ultrasound may reveal structural abnormalities. CKD is classified into five stages based on eGFR: Stage 1 (>90 mL/min/1.73m²) with kidney damage, Stage 2 (60-89), Stage 3a (45-59), Stage 3b (30-44), Stage 4 (15-29), and Stage 5 (Treatment

Treatment focuses on slowing progression and managing complications. Medications include ACE inhibitors like lisinopril or ARBs such as losartan for blood pressure control and kidney protection. Diabetes management utilizes metformin, and newer agents like empagliflozin which show kidney protective benefits. Anemia treatment includes epoetin alfa and iron supplementation. Bone disease management involves phosphate binders like sevelamer and active vitamin D analogs such as calcitriol. Advanced CKD requires renal replacement therapy: hemodialysis, peritoneal dialysis, or kidney transplantation. Dietary modifications include protein restriction, phosphorus limitation, and sodium reduction under dietitian guidance.

Prognosis

Prognosis varies significantly by CKD stage and underlying cause. Early-stage CKD with proper management may never progress to kidney failure, while advanced stages have higher mortality risk, primarily from cardiovascular complications. Five-year survival rates range from over 95% in early stages to approximately 60% for Stage 5 CKD. Dialysis patients have a five-year survival rate of about 40%, while kidney transplant recipients enjoy significantly better outcomes with 10-year survival rates exceeding 85% for living donor transplants. Age, comorbidities, and adherence to treatment significantly impact prognosis. Early intervention and consistent medical care can dramatically slow progression and improve quality of life.

Quality of life

Living with CKD requires significant lifestyle adjustments but many patients maintain good quality of life with proper management. Dietary modifications include limiting protein (0.8-1.0 g/kg/day), reducing sodium intake, managing phosphorus and potassium as disease progresses. Regular exercise within individual limitations helps maintain cardiovascular health and bone strength. Sleep quality often improves with treatment of restless leg syndrome and proper fluid management. Mental health support is crucial, as CKD patients experience higher rates of depression and anxiety. Workplace accommodations may include flexible scheduling for medical appointments and dialysis if needed. Social support groups provide valuable peer connections. Travel remains possible with proper planning, especially for dialysis patients who can arrange treatment at destination facilities.

Pregnancy and fertility

CKD can significantly impact fertility and pregnancy outcomes. Women with mild to moderate CKD (stages 1-3) may have successful pregnancies with close monitoring, while advanced CKD poses substantial risks including preeclampsia, preterm delivery, and accelerated kidney function decline. Pregnancy planning should involve nephrology and maternal-fetal medicine specialists. Some medications require adjustment or discontinuation, particularly ACE inhibitors and ARBs which are contraindicated in pregnancy. Men with CKD may experience reduced fertility due to hormonal changes and medication effects. Dialysis patients face additional challenges, often requiring increased treatment frequency during pregnancy. Kidney transplant recipients generally have better pregnancy outcomes than dialysis patients, though immunosuppressive medications require careful management.

Children

Pediatric CKD presents unique challenges including growth retardation, developmental delays, and psychosocial impacts. Common causes in children differ from adults and include congenital anomalies, hereditary diseases like polycystic kidney disease, and glomerulonephritis. Growth hormone therapy may be necessary for children with growth failure. School accommodations include flexible scheduling for medical appointments, dietary considerations for school meals, and awareness of fatigue and concentration difficulties. Transition to adult care requires careful planning, typically beginning in mid-adolescence with gradual transfer of responsibility. Family support and pediatric psychology services help address the emotional and social challenges. Early intervention with specialized pediatric nephrology care optimizes long-term outcomes and helps children develop self-management skills.

When to see a doctor

Immediate medical attention required: Severe shortness of breath, chest pain, confusion, seizures, severe nausea and vomiting, significant decrease in urination, severe swelling, or signs of infection with fever.

Routine nephrology care needed: Persistent fatigue, mild swelling, changes in urination patterns, poor appetite, difficulty sleeping, muscle cramps, or abnormal kidney function tests detected by primary care physician. High-risk individuals should have annual kidney function screening. Any concerning symptoms in people with diabetes, hypertension, or family history of kidney disease warrant prompt evaluation.

Regional context

Limited specific data exists for CKD prevalence in the Caucasus region, though diabetes and hypertension rates in Georgia, Armenia, and Azerbaijan suggest significant CKD burden. Regional challenges include limited access to specialized nephrology care in rural areas and varying availability of dialysis facilities. Traditional dietary patterns high in sodium may contribute to hypertension-related CKD. Healthcare systems in the region are working to improve early detection and management programs. GMJ welcomes contributions from regional researchers to build the evidence base for CKD in the Caucasus, particularly regarding genetic factors, environmental influences, and optimal care delivery models for this population.

Research and clinical trials

Current research focuses on novel therapeutic targets including inflammation pathways, fibrosis mechanisms, and regenerative approaches. Promising areas include SGLT2 inhibitors showing kidney protection beyond diabetes, novel phosphate binders, and artificial kidney development. Gene therapy and stem cell research offer future potential. Clinical trials are investigating new medications for mineral bone disorders, improved dialysis techniques, and immunosuppression protocols for transplantation. Patients can find relevant clinical trials through ClinicalTrials.gov. Artificial intelligence and machine learning are being developed to predict CKD progression and optimize treatment protocols. Research into biomarkers for earlier detection and personalized treatment approaches continues to advance.

Frequently asked questions

Can kidney function improve once you have CKD?

While kidney function rarely returns to normal, early-stage CKD progression can be significantly slowed or even stabilized with proper treatment. Some acute causes of kidney injury can recover partially if underlying conditions are addressed promptly.

Do I need to follow a special diet with CKD?

Dietary needs vary by CKD stage. Early stages may only require limiting sodium and maintaining healthy eating patterns, while advanced stages need restrictions on protein, phosphorus, and potassium. Work with a renal dietitian for personalized guidance.

How long can you live on dialysis?

Many dialysis patients live for years or decades with good quality of life. Survival depends on age, overall health, adherence to treatment, and underlying conditions. Some patients successfully use dialysis as a bridge to kidney transplantation.

Is kidney transplant always better than dialysis?

For suitable candidates, kidney transplantation generally offers better long-term survival and quality of life compared to dialysis. However, transplant requires lifelong immunosuppression and carries surgical risks. The decision depends on individual health status and circumstances.

Can CKD be prevented if it runs in my family?

While genetic predisposition cannot be changed, many risk factors are modifiable. Maintaining healthy blood pressure and blood sugar, regular exercise, healthy diet, and avoiding nephrotoxic substances can significantly reduce risk even with family history.

Support and resources

International organizations:
– National Kidney Foundation (kidney.org)
– International Society of Nephrology (theisn.org)
– Kidney Disease: Improving Global Outcomes (kdigo.org)
– American Association of Kidney Patients (aakp.org)
– European Renal Association (era-edta.org)
– World Health Organization Kidney Disease Program (who.int)

Educational resources:
– National Institute of Diabetes and Digestive and Kidney Diseases (niddk.nih.gov)
– Kidney Health Australia (kidney.org.au)
– Fresenius Kidney Care patient resources

Related conditions

Diabetic nephropathy – kidney damage specifically caused by diabetes complications
Hypertensive nephropathy – kidney damage resulting from prolonged high blood pressure
Polycystic kidney disease – inherited disorder causing fluid-filled cysts in kidneys
Glomerulonephritis – inflammation of kidney filtering units
Acute kidney injury – sudden loss of kidney function over hours to days

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.